dr. seidman on paclitaxel schedules as adjuvant therapy for breast cancer
Published 11 years ago • 342 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
1:10
dr. andrew d. seidman on targeted treatments in breast cancer
-
1:54
nab-paclitaxel as neoadjuvant therapy for breast cancer
-
0:48
andrew seidman, md: treatment goals for patients with tnbc
-
1:45
nab-paclitaxel as neoajuvant therapy for breast cancer
-
1:20
dr. andrew d. seidman on the lack of a biomarker in certain breast cancers
-
7:11
case 1: adjuvant therapy for residual disease in her2 breast cancer
-
1:56
apt: adjuvant paclitaxel and trastuzumab for node-negative, her2 breast cancer
-
1:56
exploring extended adjuvant endocrine therapy for hr breast cancer
-
0:21
taxol #chemotherapy for #breastcancer (paclitaxel)
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
0:44
andrew seidman, md: third-line options to prolong life
-
1:15
dr. burstein on the follow-up of apt trial for her2 breast cancer
-
1:34
andrew seidman, md: main indications for dose reduction with eribulin
-
0:54
dr. seidman on ixabepilone in patients with aggressive breast cancer
-
5:15
case review: t-dm1 for residual her2 breast cancer
-
0:58
andrew seidman, md: candidacy for eribulin therapy
-
0:52
dr. andrew seidman on personalized and precision medicine in cancer
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
0:47
dr. shulman on chemotherapy in adjuvant breast cancer